Comparison of vascularity and angiogenesis in primary invasive mammary carcinomas and in their respective axillary lymph node metastases

Clinical and Experimental Metastasis

Volumn 18, Issue 8, 2000, Pages 695-702

  Edel, Michael J ^a   Harvey, Jennet M ^b   Papadimitriou, John M ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Angiogenic potential; Invasive mammary carcinoma; Lymph node metastasis; Metastatic clone; Vascularity

Indexed keywords

ANGIOGENESIS; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER LOCALIZATION; CELL CLONE; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; LYMPH FLOW; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; PROMOTER REGION; SECOND CANCER; THEORY; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0035681143     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013139022051     Document Type: Article

References (45)

1. How is blood vessel growth regulated in normal and neoplastic tissue?
2. Vascular endothelial growth factor is a secreted angiogenic mitogen
3. Expression of vascular endothelial growth factor, its recptor and other angiogenic factors in human breast cancer
4. Endostatin: An endogenous inhibitor of angiogenesis and tumour growth
5. Locally increased metastatic efficiency as a reason for preferential metastasis of solid tumours to lymph nodes
6. The pathobiology of metastasis within the lymphatic system
7. Influence of a lymph node environment on invasiveness of metastatic tumour cells
8. High endothelial venules (HEVs): Specialized endothelium for lymphocyte migration
9. What can we learn from the phenomenon of preferential lymph node metastasis in carcinoma
10. In vitro rapid organisation of endothelial cells into capillary-like networks is promoted by collagen matrices
11. Endothelial cell proliferation during angiogenesis In vitro modulation by basement membrane components
12. Critical factors controlling angiogenesis: Cell products, cell matrix and growth factors
13. Fibrin-containing gels induce angiogenesis: Implications for tumor stroma generation and wound healing
14. Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration
15. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures
16. Mechanico-chemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: Role of extracellular matrix
17. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo
18. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro
19. The effect of extracellular matrix molecules on the in vitro behavior of bovine endothelial cells
20. Effect of host microenviroment on the microcirculation of human colon adenocarcinoma
21. Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis
22. Association of angiogenesis in lymph node metastases with outcome of breast cancer
23. Angiogenesis in invasive breast carcinoma: Is it associated with parameters of prognostic significance?
24. Microvessel density in unknown primary tumours
25. Tumor angiogenesis in primary and metastatic colorectal cancers
26. Growth dominance of the metastatic cancer cell: Cellular and molecular aspect
27. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
28. Assessment of vascularity in breast carcinoma by computer-assisted video analysis (CAVA) and its association with axillary lymph node status
29. At convenience and systematic random sampling: Effects on the prognostic value of nuclear area assessments in breast cancer patients
30. Monoclonal antibody Ki-67: Its use in histopathology
31. Which proliferation markers for routine immunohistology? A comparison of five antibodies
32. Usefulness of MIB1 monoclonal antibody in assessing proliferative index in human bladder carcinoma: Comparison with Ki-67 antibody
33. Ki-67 staining as a means to simplify analysis of tumour cell proliferation
34. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections
35. Detection of Ki-67 proliferation rate in breast cancer
36. Quantitative image analysis of MIB1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast
37. The distribution of secondary growth in cancer of the breast
38. Tumor heterogeneity and the biology of cancer invasion and metastasis
39. Angiogenesis in primary lung cancer and lung secondaries
40. Tumour cells are protected from NK-cell mediated lysis by adhesion to endothelial cells
41. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
42. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumour and produces long-term dormancy of metastases